In an international transaction that can be described only as utterly weird and unprecedented, a Russian cannabis company has purchased Ebola.com for just over $200,000, reports Time Magazine. To make matters stranger, a significant portion of the funds came from stock in Cannabis Sativa, a different marijuana company based out of Nevada.
The Russian company, now going under the name Weed Growth Fund, was as recently as last month a company self-proclaimed to specialize in “stainless steel cookware products for retail and wholesale customers in North America,” called Ovation Research.
Weed Growth Fund paid $50,000 in cash and $164,000 worth in Cannabis Sativa stock to a disease-obsessed domain name vendor called Blue String Ventures.
Another interesting side note — which could partially explain Weed Growth Fund’s interest in Ebola.com — is that Gary Johnson, current CEO of Cannabis Sativa and former governor of New Mexico, has publicly suggested that medical marijuana could provide a possible treatment for Ebola. Whether Johnson’s position at the head of Cannabis Sativa had any influence in the transferring of that company’s stock for Ebola.com, however, is uncertain.
Photo Credit: NIAID
Get daily cannabis business news updates. Subscribe